BrexitDB.com
Home
Themes
Types
DB
About
item:
#1487
Recardio puts the brakes on new heart drug trials in U.K. over Brexit concerns
03/10/2018
San Francisco-based clinical-stage life science company Recardio is halting clinical trials in the U.K. of a new heart drug due to concerns about Brexit and how new drugs will be approved.
https://www.fiercebiotech.com/
news
clinical trials
health
medicine
Recardio